All posts tagged
German Drug to Stop the Progression of Alzheimer’s Enters Phase IIb
German Scientists Publish New Mechanism of Action Against Alzheimer’s
German Biotech Unveils Positive Phase II Results for Alzheimer’s
A Dutch University Hospital has Halted Amyloid Beta Drug Studies
10 Hot European Biotechs to Observe in 2017 🚀
What does ‘Anti-Aging Treatment’ mean in Biotech?
Following Eli Lilly’s Failure, what’s Next in Alzheimer’s Treatments?
Leading German Biotech recruits New talent for Fight against Alzheimer’s
To IPO or not to IPO when you are a Biotech company? #BIO-Europe 2015
New Cognitive-Enhancement Antibody enlightens Alzheimer’s ridden Mice
2014, the Biggest Year Ever for European Biotech IPOs
Labiotech UG, All Rights Reserved -
Send this to a friend